首页> 外文期刊>Chemistry Select >Design and Development of Distinct Tetracyanoquinodimethane Derivatives Exhibiting Dual Effect of Fluorescence and Anticancer Activity
【24h】

Design and Development of Distinct Tetracyanoquinodimethane Derivatives Exhibiting Dual Effect of Fluorescence and Anticancer Activity

机译:荧光和抗癌活性的双重作用的独特四喹啉二甲烷衍生物的设计和开发

获取原文
获取原文并翻译 | 示例
           

摘要

Tetracyanoquinodimethane (TCNQ) is known to react with primary/secondary amines to generate mono/di-substituted TCNQ derivatives resulting in optical (fluorescence) and non- linear optical characteristics. However, the choice of amine plays a key role in the sequel of certain material attributes. Nevertheless, demonstration of TCNQ derivatives, specifically obtained by reacting TCNQ with simple & small amine side chains of existing anticancer drugs, emerging in dual effect of fluorescence as well as anticancer activity, is not explored so far and has been still existing as a gap in TCNQ related research. Additionally, mono/di-substituted TCNQ’s owning strong fluorescence in solutions (-10 to 104 order) than their solids are still lacking and are in need to be generated. In this regard, we aimed to synthesize straightforward TCNQ derivatives in single step by reacting TCNQ with specific (simple and small) amines being side chains of existing anticancer drugs (a contemporary design approach) and successfully obtained novel mono/di-substituted TCNQ derivatives manifesting dual effect of fluorescence and anticancer activity. In this fashion, we have avoided the usage of bulky main moiety of an anticancer molecule, since our aim was not to use the total anticancer drug as such, like in a Pro-drug preparation, but we intended to use the minimal part of an anticancer drug to invent novel TCNQ derivatives as anticancer active fluoro- phores. Wavelength of maximum emission for all the five potent molecules was within -525 nm-696 nm. All compounds showed moderate anticancer activity against different cancer cell lines and IC50 values were in the range of 11 to 49 μM, when the synthesized novel compounds were tested in B16F10, MDA-MB-231 and A549 cell lines. Henceforth, this study has emanated in the first generation TCNQ derivatives as organic fluorescent anticancer active molecules.
机译:已知四酰基喹啉甲烷(TCNQ)与初级/次级胺反应,从而产生单/二取代的TCNQ衍生物,从而产生光学(荧光)和非线性光学特性。但是,胺的选择在某些材料属性的续集中起关键作用。然而,尚未探索尚未探索TCNQ衍生物,该示范是通过与现有抗癌药物的简单和小胺侧链反应的特异性获得的,到目前为止尚未探索荧光和抗癌活性的双重效应,并且仍未作为荧光的双重作用。 TCNQ相关研究。此外,比其固体比其固体具有强的溶液(-10至104顺序)具有强烈的荧光(-10至104顺序),而其固体仍然缺乏且需要生成。在这方面,我们的目的是通过与特定(简单和小的)胺反应TCNQ是现有抗癌药物的侧链(一种现代设计方法),并成功获得了新颖的Mono/di-subsubStuded TCNQ衍生物表现出的新型抗癌药物(一种现代设计方法),以单一步骤合成直接的TCNQ衍生物。荧光和抗癌活性的双重作用。以这种方式,我们避免使用抗癌分子的庞大主要部分,因为我们的目的不是使用总抗癌药物,例如在亲毒品的准备中,但我们打算使用最小的部分抗癌药以发明新型TCNQ衍生物作为抗癌活性氟苯酚。所有五个有效分子的最大发射波长均在-525 nm -696 nm之内。当在B16F10,MDA-MB-231和A549细胞系中测试合成的新型化合物时,所有化合物均对不同癌细胞系的中等抗癌活性,IC50值在11至49μm的范围内。此后,这项研究在第一代TCNQ衍生物中散发为有机荧光抗癌活性分子。

著录项

  • 来源
    《Chemistry Select》 |2021年第29期|7354-7366|共13页
  • 作者单位

    Department of Chemistry, Birla Institute of Technology and Science, Pilani-Hyderabad Campus, Jawaharnagar, Shameerpet Mandal, Medchal Dist. Hyderabad - 500078, Telangana State, India;

    Epigenetic Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani-Hyderabad Campus, Jawaharnagar, Shameerpet Mandal, Medchal Dist. Hyderabad - 500078, Telangana State, India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 Online;
  • 关键词

    tetracyanoquinodimethane; Antineoplastic Agents; FluorescenceAmines;

    机译:四甲苯二甲烷;抗肿瘤剂;荧光甲氨酸甲烷;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号